Combination therapy of sorafenib with mesenchymal stem cells as a novel cancer treatment regimen in xenograft models of hepatocellular carcinoma.

Iman SeyhounSaieh HajighasemlouSamad MuhammadnejadJafar AiMohsen NikbakhtAli Akbar AlizadehFaezeh HosseinzadehMilad MirmoghtadaeiSeyed Moein SeyhounJavad Verdi

Published in: Journal of cellular physiology (2018)

This combination therapy strategy could be used as a new therapeutic approach to the treatment of HCC that significantly improves upon the results achieved using sorafenib as monotherapy.

Keyphrases

combination therapy
mesenchymal stem cells
umbilical cord
randomized controlled trial
clinical trial
open label